Literature DB >> 18308772

Peritoneal dialysis in children under two years of age.

Hanne Laakkonen1, Tuula Hölttä, Tuula Lönnqvist, Christer Holmberg, Kai Rönnholm.   

Abstract

BACKGROUND: Although results of peritoneal dialysis (PD) in small children have improved during recent years, the youngest children have poorer growth, more infections and higher mortality than do older children.
METHODS: In this retrospective study, we analysed patient records of all children under age 2 treated with continuous peritoneal dialysis (CPD) between 1995 and 2000 in Finland. Diagnoses leading to renal failure in these 23 children were congenital nephrotic syndrome of the Finnish type (13), polycystic kidney disease (4), a urethral valve (3), renal insufficiency due to neonatal asphyxia (2) and Prune-Belly syndrome (1). Of these 23, 17 (74%) were anuric.
RESULTS: The mean age at the onset of PD was 0.4 years and the mean time on dialysis 1.4 years. Hernias were diagnosed in 57%. The peritonitis rate was 1:14.5 patient-months, and 30% were peritonitis-free. Hypertension was common, and 70% had at least one period on antihypertensive medication. None of the patients had pulmonary oedema or dialysis-related seizures. The mean height standard deviation score (hSDS) at the start of PD (n = 16) was -2.0 and after 9 months -1.6. Catch-up growth was documented in 64% of the patients during dialysis. Hospitalization time was 124 days/patient-year. Two patients (9%) died.
CONCLUSIONS: Our results are reassuring. Mortality was low, laboratory parameters were acceptable and growth was good. Peritonitis rate was comparable to that in older children. Correction of inguinal hernia should be routinely performed; high blood pressure is still a problem.

Entities:  

Mesh:

Year:  2008        PMID: 18308772     DOI: 10.1093/ndt/gfn035

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

1.  Peritoneal Dialysis Access Revision in Children: Causes, Interventions, and Outcomes.

Authors:  Dagmara Borzych-Duzalka; T Fazil Aki; Marta Azocar; Colin White; Elizabeth Harvey; Sevgi Mir; Marta Adragna; Erkin Serdaroglu; Rajiv Sinha; Charlotte Samaille; Juan Jose Vanegas; Jameela Kari; Lorena Barbosa; Arvind Bagga; Monica Galanti; Onder Yavascan; Giovanna Leozappa; Maria Szczepanska; Karel Vondrak; Kei-Chiu Tse; Franz Schaefer; Bradley A Warady
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-29       Impact factor: 8.237

Review 2.  Sustaining life or prolonging dying? Appropriate choice of conservative care for children in end-stage renal disease: an ethical framework.

Authors:  Janis M Dionne; Lori d'Agincourt-Canning
Journal:  Pediatr Nephrol       Date:  2014-10-21       Impact factor: 3.714

3.  Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA Registry.

Authors:  Tuula Hölttä; Marjolein Bonthuis; Karlijn J Van Stralen; Anna Bjerre; Rezan Topaloglu; Fatih Ozaltin; Christer Holmberg; Jerome Harambat; Kitty J Jager; Franz Schaefer; Jaap W Groothoff
Journal:  Pediatr Nephrol       Date:  2016-10-20       Impact factor: 3.714

4.  Survival and transplantation outcomes of children less than 2 years of age with end-stage renal disease.

Authors:  R Todd Alexander; Bethany J Foster; Marcello A Tonelli; Andrea Soo; Alberto Nettel-Aguirre; Brenda R Hemmelgarn; Susan M Samuel
Journal:  Pediatr Nephrol       Date:  2012-06-07       Impact factor: 3.714

5.  Peritoneal dialysis and infants: further insights into a complicated relationship.

Authors:  Enrico Vidal
Journal:  Pediatr Nephrol       Date:  2017-12-07       Impact factor: 3.714

6.  Renal replacement therapy in infants with chronic renal failure in the first year of life.

Authors:  Mirja Wedekin; Jochen H H Ehrich; Gisela Offner; Lars Pape
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-12       Impact factor: 8.237

7.  Normal growth and intravascular volume status with good metabolic control during peritoneal dialysis in infancy.

Authors:  Hanne Laakkonen; Juha-Matti Happonen; Eino Marttinen; Aila Paganus; Tuula Hölttä; Christer Holmberg; Kai Rönnholm
Journal:  Pediatr Nephrol       Date:  2010-05-06       Impact factor: 3.714

8.  Growth hormone treatment of infants with chronic kidney disease: requirement, efficacy, and safety.

Authors:  Dieter Haffner; Dagmar-Christiane Fischer
Journal:  Pediatr Nephrol       Date:  2009-04-17       Impact factor: 3.714

9.  Successes and pitfalls of chronic peritoneal dialysis in infants - a Polish nationwide outcome study.

Authors:  Anna Jander; Irena Makulska; Joanna Latoszyńska; Hanna Boguszewska-Bączkowska; Irena Bałasz-Chmielewska; Ilona Zagożdżon; Iga Załuska-Leśniewska; Ewa Stefaniak; Beata Leszczyńska; Katarzyna Zachwieja; Ryszard Wierciński; Hanna Kipigroch; Barbara Kołłątaj; Marcin Tkaczyk
Journal:  Arch Med Sci       Date:  2010-06-30       Impact factor: 3.318

Review 10.  Chronic peritoneal dialysis in children.

Authors:  Nia Fraser; Farida K Hussain; Roy Connell; Manoj U Shenoy
Journal:  Int J Nephrol Renovasc Dis       Date:  2015-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.